| Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377) |
|---|
| 04/08/2009 | CN101405338A Use of particular polymers or copolymers as surfactants for stabilizing latices |
| 04/08/2009 | CN101405337A Process of controlled free-radical polymerization or copolymerization of one or more monomers in the presence of an alkoxyamine initiator |
| 04/08/2009 | CN101405293A Lysme-based prodrugs of aspartyl protease inhibitors and processes for their preparation |
| 04/08/2009 | CN101405292A Method for the purification of triorganophosphites by treatment with a basic additive |
| 04/08/2009 | CN101402654A Method for recycling sodium glyphosate with air-float solvent floatation |
| 04/08/2009 | CN101402653A Method for abstracting and recycling sodium glyphosate with assistance of microwave |
| 04/08/2009 | CN101402652A Circulation production process for glyphosate |
| 04/08/2009 | CN100475825C Acyclic nucleoside phosphonate derivatives |
| 04/08/2009 | CN100475824C Novel phosphonic acid compounds as inhibitors of serine proteases |
| 04/08/2009 | CN100475778C Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient |
| 04/07/2009 | US7514556 Inhibitors of β-lactamase |
| 04/07/2009 | US7514520 Forming a polyphosphazene by reacting a cyclic and/or linear phosphonitrile with an alcohol or phenol in a solvent in the presence of an ammonium halometallate, such as (NH4)3ZnCl5 |
| 04/07/2009 | US7514462 ω-Cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists |
| 04/07/2009 | US7514419 Phosphorus-containing thyromimetics |
| 04/07/2009 | CA2463815C Pharmaceutically acceptable alendronate salts in amorphous form |
| 04/07/2009 | CA2453382C Mannitol and glucitol derivatives |
| 04/07/2009 | CA2385721C Electrochromic device |
| 04/07/2009 | CA2343962C Process for preparing carboxylic acids |
| 04/07/2009 | CA2300071C Novel compounds for generating chemiluminescence with a peroxidase |
| 04/07/2009 | CA2256828C Process for the manufacture of bis(phosphine oxide)-and bis(phosphonate)- compounds |
| 04/02/2009 | WO2009042179A1 Crystalline forms of ibandronic acid and processeses for the preparation thereof |
| 04/02/2009 | WO2009040007A1 Insecticidal derivatives of phosphorylated aminoheterocycles |
| 04/02/2009 | WO2009003001A3 Preparation of risedronate sodium hemi-pentahydrate |
| 04/02/2009 | WO2008152518A3 Process for the preparation of risedronic acid or risedronate sodium |
| 04/02/2009 | US20090088517 Curing compositions for fluoropolymers |
| 04/02/2009 | US20090088414 Soluble 17-amino-analogs of geldanamycin in acid addition salt form; water solubility; anticancer agents; storage stability |
| 04/02/2009 | US20090088407 Compounds, methods and pharmaceutical compositions for inhibiting parp |
| 04/02/2009 | US20090087492 Processes and Apparatuses for the Production of Crystalline Organic Microparticle Compositions by Micro-Milling and Crystallization on Micro-Seed and Their Use |
| 04/02/2009 | US20090087420 Stable solution of reduced coenzyme q |
| 04/02/2009 | US20090085006 Activators for oligonucleotide synthesis |
| 04/01/2009 | EP2042507A1 Insecticidal derivatives of phosphorylated aminoheterocycles |
| 04/01/2009 | EP2041148A1 Novel process for the preparation of bisphosphonic acids |
| 04/01/2009 | EP1506175B1 N-substituted tricyclic 3-aminopyrazoles as pdgf receptor inhibitors |
| 04/01/2009 | EP1378532B1 Polymer containing 9-oxo-9-phosphafluorene-2,7-diyl skeleton in backbone and process for producing the same |
| 04/01/2009 | CN101400685A New alkoxyamines, process for preparing them and their use in free-radical polymerization |
| 04/01/2009 | CN100473669C Organometallic transition metal compound, biscyclopentadienyl ligand system, catalyst system and preparation of polyolefins |
| 04/01/2009 | CN100473655C Method for preparing no-halogen fire-proof phosphorus-containing compound |
| 04/01/2009 | CN100473646C Polymerization with living characteristics |
| 04/01/2009 | CN100473644C 9-substituted minocycline compounds |
| 03/31/2009 | US7511178 Hydroformylation of aqueous formaldehyde in the presence of a coordination catalyst preferably comprising rhodium dicarbonyl acetonylacetone and 2-phospha-2-icosyl-1,3,5,7-tetramethyl-6,9,10-trioxa-tricyclo[3.3.1.1{3,7}]-decane; hydrogenation of glycolaldehyde; catalyst selectivity; cost efficiency |
| 03/31/2009 | US7511174 Reacting phosphorous trichloride or phosphorous oxychloride, phosphorous acid, and N-methyl-N-pentyl 3-aminopropionic acid or its hydrochloride salt in a diluent; heating; forming biphasic solution with water; heating, evaporating water; adding a C2-4 alcohol or acetone to precipitate |
| 03/31/2009 | US7511170 Insoluble reaction product; elongation reaction zone; controlling viscosity;separartion; filtration |
| 03/31/2009 | US7511167 Emission of high intensity fluorescence in environment of cell membrane; detection hydrophilic, hydrophobic domains |
| 03/31/2009 | US7511154 For producing (1'benzyl-2-oxo-[1,3']-(R)-bipyrrolidinyl-3-(R,S)-yl)-triphenyl-phosphonium bromide which is an intermediate for antibacterial vinylpyrrolidinone-cephalosporin derivatives, starting with N-benzyl-3-pyrrolidinamine |
| 03/31/2009 | US7511084 Photoinitiators; phosphine oxide structure with hydroxylamino, alkoxylamino, or hydrazido groups on the central phosphorus atom; simple synthesis; high tolerance to functional groups, very low tendency to migrate; photographic materials, radiation curing of photopolymerizable coatings, inks, dispersions |
| 03/31/2009 | US7511051 Cidofovir peptide conjugates as prodrugs |
| 03/31/2009 | US7510784 Light emitting device formed using rare earth complex and luminescent medium |
| 03/31/2009 | CA2292549C Use of colchinol derivatives as vascular damaging agents |
| 03/26/2009 | WO2009037251A2 Coordination complex of a metal and a polymer incorporating phosphorus atoms and uses employing such a complex |
| 03/26/2009 | WO2009036909A1 Halosubstituted aryloxyalkylimidazolines for use as pesticides |
| 03/26/2009 | WO2009036908A1 Halosubstituted aryloxyalkylimidazolines for use as pesticides |
| 03/26/2009 | WO2009006979A3 Catalyst composition and process for di-, tri- and/or tetramerization of ethylene |
| 03/26/2009 | US20090082571 Intermediates of 2-substituted carbapenem derivatives and process for production thereof |
| 03/26/2009 | US20090082569 Narcistatin prodrugs |
| 03/26/2009 | US20090082524 Water-Soluble and Water-Insoluble, Ring Opening Metathesis Polymerization Products, Monomers and Related Methods |
| 03/26/2009 | US20090082312 Deuterium-enriched zoledronic acid |
| 03/26/2009 | US20090082311 2-Aminobutanol Compound and Use Thereof for Medical Purposes |
| 03/26/2009 | US20090078574 Charge tags and the separation of nucleic acid molecules |
| 03/25/2009 | EP2039698A1 Phosphorus molybdenum compound and method for producing the same |
| 03/25/2009 | EP2039361A2 Use of immunomodulatory compounds |
| 03/25/2009 | EP2038292A1 Cyclic phosphazene compound |
| 03/25/2009 | EP2038291A2 Process for the synthesis of ibandronate sodium |
| 03/25/2009 | EP2038290A1 Modulators of toll-like receptor 7 |
| 03/25/2009 | EP2038274A2 Transcription factor modulating compounds and methods of use thereof |
| 03/25/2009 | EP2038248A2 Combination of ceramide and oxaliplatin for inducing cell death and uses thereof in treating cancer |
| 03/25/2009 | EP2038241A1 Electroluminescent polymers and use thereof |
| 03/25/2009 | CN101395166A Compounds and methods for the treatment of cancer |
| 03/25/2009 | CN101395165A Ligand, method for producing the same, and catalyst using the ligand |
| 03/25/2009 | CN101395164A N-(phosphonoalkyl)-amino acids, derivatives thereof and compositions and methods of use |
| 03/25/2009 | CN101395163A Methods for the diagnosis of dementia and other neurological disorders |
| 03/25/2009 | CN101395089A Nano-size euse crystal, and process for producing nano-size euse crystal |
| 03/25/2009 | CN101392006A Axial chirality diphosphine ligand containing bis-schiff base |
| 03/25/2009 | CN101392005A Method for preparing quaternary phosphonium salt compounds |
| 03/25/2009 | CN100471860C Preparing process adapted for electronic grade solid aminotrimethylene phosphonic acid |
| 03/25/2009 | CN100471858C Inhibitors of cyclin-dependent kinases, compositions and uses related thereto |
| 03/25/2009 | CN100471853C Phenyl-thiophene type vitamin D receptor modulators |
| 03/25/2009 | CN100471843C Superhigh purity ionic liquid |
| 03/25/2009 | CN100471842C Quinolone derivative or its salt |
| 03/24/2009 | US7507851 Halocombstatins and methods of synthesis thereof |
| 03/24/2009 | US7507848 Vapor deposition of metal oxides, silicates and phosphates, and silicon dioxide |
| 03/24/2009 | US7507820 Diazaphosphacycles |
| 03/24/2009 | US7507782 Transition-metal complexes with tridentate, nitrogen-containing ligands |
| 03/24/2009 | US7507750 e.g. L-Ascorbic acid-2-phosphoric acid-6-(2'-hexyldecanoate) sodium salt; collagen production accelerators; skin whitening; medical, pharmaceutical preparations, feeds, foods and agrochemicals; storage stability, |
| 03/24/2009 | US7507688 Monocyclopentadienyl complexes |
| 03/24/2009 | US7507420 Peptidyl prodrugs and linkers and stabilizers useful therefor |
| 03/24/2009 | CA2224060C Manganese or iron complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide |
| 03/19/2009 | WO2009035347A1 Peptide-lipid constructs and their use in diagnostic and therapeutic applications |
| 03/19/2009 | WO2009034580A1 Improved process for the preparation of risedronate sodium hemipentahydrate |
| 03/19/2009 | WO2009013541A3 An adduct of 1-hydroxyethylidene-l, 1-diphosphonic acid and ethylened iamine disuccinic acid or a salt thereof, a method for its preparation, and the use of said adduct |
| 03/19/2009 | US20090076299 Phosphated alcanol, its use as a hydrotrope and cleaning composition containing the compound |
| 03/19/2009 | US20090076285 Process for the treatment of an aqueous mixture comprising a dipolar aprotic compound |
| 03/19/2009 | US20090076271 Process for preparing intermediates of HMG-CoA reductase inhibitors |
| 03/19/2009 | US20090075947 Deuterium-enriched fospropofol |
| 03/19/2009 | US20090075944 Deuterium-enriched ibandronate |
| 03/19/2009 | US20090075943 Combretastatin Analogs with Tubulin Binding Activity |
| 03/19/2009 | US20090075942 Deuterium-enriched fosamprenavir |
| 03/19/2009 | US20090075940 Deuterium-enriched risedronate |
| 03/19/2009 | CA2699366A1 Peptide-lipid constructs and their use in diagnostic and therapeutic applications |
| 03/18/2009 | EP2036940A1 Polymerizable composition, resin using the same, optical component and compound |
| 03/18/2009 | EP2036912A1 Phosphorous containing benzoxazine-based monomer, polymer thererof, electrode for fuel cell including the same, electrolyte membrane for fuel cell including the same, and fuel cell employing the same |